Estimating effectiveness in an observational study: A case study of dornase alfa in cystic fibrosis
Authors:
- Steven M. ButlerSBSteven M. Butler
- Michael W. KonstanMKMichael W. Konstan
- Timothy J. BreenTBTimothy J. Breen
- Wayne J. MorganWMWayne J. Morgan
- 30 June 1999
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 134 (6) , 734-739
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Relationship between socioeconomic status and disease severity in cystic fibrosisThe Journal of Pediatrics, 1998
- Identifying Treatments That Halt Progression of Pulmonary Disease in Cystic FibrosisPediatric Research, 1997
- Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Management of Pulmonary Disease in Patients with Cystic FibrosisNew England Journal of Medicine, 1996
- Gender differences in cystic fibrosis: Pseudomonas aeruginosa infectionJournal of Clinical Epidemiology, 1995
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Mucociliary Clearance in Patients with Cystic Fibrosis and in Normal SubjectsAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Pathogenesis of cystic fibrosisThe Lancet, 1993
- Cystic Fibrosis Foundation Guidelines for Patient Services, Evaluation, and Monitoring in Cystic Fibrosis CentersAmerican Journal of Diseases of Children, 1990
- CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASEA.M.A. American Journal of Diseases of Children, 1938